新型炎症标志物与急性冠脉综合征的相关性研究进展
Research Progress on Correlation between Acute Coronary Syndrome and Some Novel Inflammatory Markers
DOI: 10.12677/ACM.2023.1392126, PDF,   
作者: 王 琼, 刘志强*：新疆医科大学第一附属医院心脏中心，新疆 乌鲁木齐
关键词: 急性冠脉综合征；炎症因子；相关性；Acute Coronary Syndrome； Inflammatory Factor； Correlation
摘要: 全身及局部炎症反应在急性冠脉综合征(acute coronary syndrome, ACS)发生、发展及预后的病理生理过程中起着至关重要的作用。在临床中监测炎症相关标志物有利于对ACS进行危险分层、预后评估以及尽早采取干预措施。因此，与ACS相关简单易得的血清标志物受到国内外广泛研究，血小板/淋巴细胞比值(PLR)、中性粒细胞/淋巴细胞计数比值(NLR)、白细胞计数/平均血小板体积比值(WMR)、单核细胞/高密度脂蛋白胆固醇(MHR)、单核细胞/淋巴细胞比值(MLR)作为新型炎症标志物，在临床工作中对ACS的进展、危险分层以及预后评估具有重要临床价值。本文系统总结了上述新型炎症标志物在ACS中的研究进展。
Abstract: Systemic and local inflammation plays an important role in the pathogenesis, development and prognosis of acute coronary syndrome (ACS). Clinical monitoring of inflammation-related markers is beneficial for risk stratification, prognosis assessment and early intervention of ACS. Therefore, the simple and easily obtained serum markers associated with ACS have been widely studied at home and abroad. Platelet/lymphocyte ratio (PLR), neutrophil/lymphocyte count ratio (NLR), white blood cell count/mean platelet volume ratio (WMR), monocyte/high-density lipoprotein cholesterol (MHR), and monocyte/lymphocyte ratio (MLR) as novel inflammatory markers. In clinical work, it has important clinical value for the progression, risk stratification and prognosis assessment of ACS. This article systematically summarizes the research progress of these novel inflammatory markers in ACS.
文章引用：王琼, 刘志强. 新型炎症标志物与急性冠脉综合征的相关性研究进展[J]. 临床医学进展, 2023, 13(9): 15202-15208. https://doi.org/10.12677/ACM.2023.1392126

参考文献

[1] Bhatt, D.L., Lopes, R.D. and Harrington, R.A. (2022) Diagnosis and Treatment of Acute Coronary Syndromes: A Re-view. JAMA, 327, 662-675. [Google Scholar] [CrossRef] [PubMed]
[2] 张楠, 陆莹. 中性粒细胞/淋巴细胞比值与急性冠脉综合征相关性的研究进展[J]. 中国急救医学, 2021, 41(3): 265-269.
[3] Samstag, Y., Bogert, N.V., Wabnitz, G.H., et al. (2020) Reactive Oxidative Species-Modulated Ca(2+) Release Regulates beta(2) Integrin Activation on CD4(+) CD28(null) T Cells of Acute Coronary Syndrome Patients. The Journal of Immunology, 205, 2276-2286. [Google Scholar] [CrossRef] [PubMed]
[4] 李小静, 闫卫军. 血清可溶性白介素-6受体、基质金属蛋白酶-9和白介素-18水平对急性ST段抬高心肌梗死合并心力衰竭患者左心功能的影响[J]. 内科急危重症杂志, 2020, 26(4): 321-324.
[5] 阮文婷, 魏希进, 管琳. 血清NT-proBNP、Gal-3水平与急性ST段抬高型心肌梗死患者病情及近期预后的关系[J]. 中华保健医学杂志, 2022, 24(3): 192-195.
[6] Garzotto, M., Higano, C.S., O’brien, C., et al. (2010) Phase 1/2 Study of Preoperative Docetaxel and Mitoxantrone for High-Risk Prostate Cancer. Cancer, 116, 1699-1708. [Google Scholar] [CrossRef] [PubMed]
[7] Shumilah, A.M., Othman, A.M. and Al-Madhagi, A.K. (2021) Accuracy of Neutrophil to Lymphocyte and Monocyte to Lymphocyte Ratios as New Inflammatory Markers in Acute Coronary Syndrome. BMC Cardiovascular Disorders, 21, Article No. 422. [Google Scholar] [CrossRef] [PubMed]
[8] Núñez, J., Sastre, C., D’ascoli, G., et al. (2020) Relation of Low Lymphocyte Count to Frailty and Its Usefulness as a Prognostic Biomarker in Patients > 65 Years of Age with Acute Coronary Syndrome. American Journal of Cardiology, 125, 1033-1038. [Google Scholar] [CrossRef] [PubMed]
[9] Bandini, M., Fossati, N., Gandaglia, G., et al. (2018) Neoadju-vant and Adjuvant Treatment in High-Risk Prostate Cancer. Expert Review of Clinical Pharmacology, 11, 425-438. [Google Scholar] [CrossRef] [PubMed]
[10] Bergstrom, C.P., Ruffell, B., Ho, C.M., et al. (2017) Docet-axel and Mitoxantrone before Radical Prostatectomy in Men with High-Risk Prostate Cancer: 10-Year Follow-Up and Immune Correlates. Anticancer Drugs, 28, 120-126. [Google Scholar] [CrossRef] 
[11] Yildiz, A., Yuksel, M., Oylumlu, M., et al. (2015) The Utility of the Platelet-Lymphocyte Ratio for Predicting No Reflow in Patients with ST-Segment Elevation Myocardial In-farction. Clinical and Applied Thrombosis/Hemostasis, 21, 223-228. [Google Scholar] [CrossRef] [PubMed]
[12] Kim, J., Song, T.J., Park, J.H., et al. (2012) Different Prognostic Value of White Blood Cell Subtypes in Patients with Acute Cerebral Infarction. Atherosclerosis, 222, 464-467. [Google Scholar] [CrossRef] [PubMed]
[13] Kurtul, A., Murat, S.N., Yarlioglues, M., et al. (2014) Association of Platelet-to-Lymphocyte Ratio with Severity and Complexity of Coronary Artery Disease in Patients with Acute Coronary Syndromes. American Journal of Cardiology, 114, 972-978. [Google Scholar] [CrossRef] [PubMed]
[14] Temiz, A., Gazi, E., Güngör, Ö., et al. (2014) Plate-let/Lymphocyte Ratio and Risk of In-Hospital Mortality in Patients with ST-Elevated Myocardial Infarction. Medical Science Monitor, 20, 660-665. [Google Scholar] [CrossRef] 
[15] Zhou, D., Fan, Y., Wan, Z., et al. (2016) Platelet-to-Lymphocyte Ratio Improves the Predictive Power of GRACE Risk Score for Long-Term Cardiovascular Events in Patients with Acute Coronary Syndrome. Cardiology, 134, 39-46. [Google Scholar] [CrossRef] [PubMed]
[16] Maimaiti, A., Li, Y., Wang, Y.T., et al. (2019) Association of Plate-let-to-Lymphocyte Count Ratio with Myocardial Reperfusion and Major Adverse Events in Patients with Acute Myocar-dial Infarction: A Two-Centre Retrospective Cohort Study. BMJ Open, 9, e025628. [Google Scholar] [CrossRef] [PubMed]
[17] 郭静. 血小板/淋巴细胞比值与急性冠状动脉综合征的相关性研究进展[J]. 现代医药卫生, 2019, 35(16): 2486-2489.
[18] Ong, S.B., Hernández-Reséndiz, S., Crespo-Avilan, G.E., et al. (2018) Inflammation Following Acute Myocardial Infarction: Multiple Players, Dynamic Roles, and Novel Therapeutic Opportunities. Pharmacology & Therapeutics, 186, 73-87. [Google Scholar] [CrossRef] [PubMed]
[19] 任良强, 侯晓晓, 乔平, 等. WMR、RDW、NLR水平与急性心肌梗死患者PCI术后发生主要不良心血管事件的关系[J]. 中国现代医学杂志, 2022, 32(2): 74-79.
[20] Wang, J., Li, X., Pu, J., et al. (2019) Mean Platelet Volume and Coronary Plaque Vulnerability: An Optical Coherence Tomography Study in Patients with Non-ST-Elevation Acute Coronary Syndrome. BMC Cardiovascular Disorders, 19, Article No. 128. [Google Scholar] [CrossRef] [PubMed]
[21] Mohammed, A.A., Liu, L., Mareai, R.M., et al. (2022) Combination of White Blood Cell Count to Mean Platelet Volume Ratio and Neutro-phil-to-Platelet Ratio Predicts Long-Term Adverse Events in Patients with MINOCA. Mediators of Inflammation, 2022, Article ID: 5642406. [Google Scholar] [CrossRef] [PubMed]
[22] Dehghani, M.R., Rezaei, Y. and Taghipour-Sani, L. (2015) White Blood Cell Count to Mean Platelet Volume Ratio as a Novel Non-Invasive Marker Predicting Long-Term Outcomes in Patients with Non-ST Elevation Acute Coronary Syndrome. Journal of Cardiology, 22, 437-445. [Google Scholar] [CrossRef] 
[23] Emre, A.R., Yasar, K.A., Atakan, Y., et al. (2020) Relation-ship between White Blood Count to Mean Platelet Volume Ratio and Clinical Outcomes and Severity of Coronary Artery Disease in Patients Undergoing Primary Percutaneous Coronary Intervention. Cardiovascular Therapeutics, 2020, Arti-cle ID: 9625181. [Google Scholar] [CrossRef] [PubMed]
[24] Sivri, S., Sokmen, E., Celik, M., et al. (2019) Usefulness of White Blood Cell Count to Mean Platelet Volume Ratio in the Prediction of SYNTAX Score in Patients with Non-ST Elevation Myocardial Infarction. Pakistan Journal of Medical Sciences, 35, 824-829. [Google Scholar] [CrossRef] [PubMed]
[25] 刘礼富. 急性心肌梗死患者白细胞计数与平均血小板体积比值意义探讨[J]. 中国预防医学杂志, 2019, 20(3): 221-224.
[26] Newby, A.C. (2012) Matrix Metalloproteinase Inhibi-tion Therapy for Vascular Diseases. Vascular Pharmacology, 56, 232-244. [Google Scholar] [CrossRef] [PubMed]
[27] 方钊, 蒋学俊, 陶波, 等. 中性粒细胞/淋巴细胞比值与急性冠脉综合征的相关性[J]. 心脏杂志, 2018, 30(5): 517-519.
[28] 王夏芹, 何非, 王同, 等. 中性粒细胞/淋巴细胞比率对预测不稳定心绞痛患者冠脉病变严重程度和临床风险的意义[J]. 中国临床药理学与治疗学, 2019, 24(3): 296-300.
[29] Zhang, S., Diao, J., Qi, C., et al. (2018) Predictive Value of Neutrophil to Lymphocyte Ratio in Patients with Acute ST Segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention: A Meta-Analysis. BMC Cardiovascular Disorders, 18, Article No. 75. [Google Scholar] [CrossRef] [PubMed]
[30] Dentali, F., Nigro, O., Squizzato, A., et al. (2018) Impact of Neutrophils to Lymphocytes Ratio on Major Clinical Outcomes in Pa-tients with Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of the Literature. International Journal of Cardiology, 266, 31-37. [Google Scholar] [CrossRef] [PubMed]
[31] Oylumlu, M., Oylumlu, M., Arik, B., et al. (2021) Monocyte to High-Density Lipoprotein Cholesterol and Lymphocyte to Monocyte Ratios Are Predictors of In-Hospital and Long-Term Mortality in Patients with Acute Coronary Syndrome. International Journal of Clinical Practice, 75, e13973. [Google Scholar] [CrossRef] [PubMed]
[32] 仇杰, 谢勇. 单核细胞/高密度脂蛋白胆固醇比值与非ST段抬高型心肌梗死患者GRACE评分的关系研究[J]. 实用心脑肺血管病杂志, 2019, 27(10): 39-44.
[33] 李莉, 李阳, 樊泽元. 外周血MHR与非ST段抬高型心肌梗死患者冠状动脉病变严重程度及预后关系研究[J]. 临床急诊杂志, 2020, 21(1): 59-64, 69.
[34] Huang, J.B., Chen, Y.S., Ji, H.Y., et al. (2020) Neutrophil to High-Density Lipoprotein Ratio Has a Superior Prognostic Value in Elderly Patients with Acute Myocardial Infarction: A Comparison Study. Lipids in Health and Disease, 19, Article No. 59. [Google Scholar] [CrossRef] [PubMed]
[35] Kalyoncuoglu, M., Biter, H., Ozturk, S., et al. (2020) Predictive Accuracy of Lymphocyte-to-Monocyte Ratio and Monocyte-to-High-Density-Lipoprotein-Cholesterol Ratio in Deter-mining the Slow Flow/No-Reflow Phenomenon in Patients with Non-ST-Elevated Myocardial Infarction. Coronary Ar-tery Disease, 31, 518-526. [Google Scholar] [CrossRef] 
[36] Çağdaş, M., Karakoyun, S., Yesin, M., et al. (2018) The Association between Monocyte HDL-C Ratio and SYNTAX Score and SYNTAX Score II in STEMI Patients Treated with Primary PCI. Acta Cardiological Sinica, 34, 23-30.
[37] Sun, M., Zhao, D., Zhang, Y., et al. (2020) Prognostic Utility of Monocyte to High-Density Lipoprotein Ratio in Patients with Acute Coronary Syndrome: A Meta-Analysis. The American Journal of the Medical Sciences, 359, 281-286. [Google Scholar] [CrossRef] [PubMed]
[38] Cetin, M.S., Ozcan Cetin, E.H., Kalender, E., et al. (2016) Mon-ocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome. Heart, Lung and Circulation, 25, 1077-1086. [Google Scholar] [CrossRef] [PubMed]
[39] Cetin, E.H., Cetin, M.S., Canpolat, U., et al. (2015) Mono-cyte/HDL-Cholesterol Ratio Predicts the Definite Stent Thrombosis after Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Biomarkers in Medicine, 9, 967-977. [Google Scholar] [CrossRef] [PubMed]
[40] Wang, Q., Ma, J., Jiang, Z., et al. (2017) Association of Lympho-cyte-to-Monocyte Ratio with In-Hospital and Long-Term Major Adverse Cardiac and Cerebrovascular Events in Patients with ST-Elevated Myocardial Infarction. Medicine (Baltimore), 96, e7897. [Google Scholar] [CrossRef] 
[41] Kiris, T., Çelik, A., Variş, E., et al. (2017) Association of Lymphocyte-to-Monocyte Ratio with the Mortality in Patients with ST-Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention. Angiology, 68, 707-715. [Google Scholar] [CrossRef] [PubMed]
[42] Chen, H., Li, M., Liu, L., et al. (2019) Monocyte/Lymphocyte Ratio Is Related to the Severity of Coronary Artery Disease and Clinical Outcome in Patients with Non-ST-Elevation Myocardial Infarction. Medicine (Baltimore), 98, e16267. [Google Scholar] [CrossRef] 
[43] Fan, Z., Ji, H., Li, Y., et al. (2017) Relationship between Monocyte-to-Lymphocyte Ratio and Coronary Plaque Vulnerability in Patients with Stable Angina. Biomarkers in Medi-cine, 11, 979-990. [Google Scholar] [CrossRef] [PubMed]
[44] 董梦雅, 徐晨博, 周娟, 等. 急性冠脉综合征患者单核细胞/淋巴细胞比值与冠状动脉病变程度的关系[J]. 临床医学研究与实践, 2023, 8(2): 17-20, 25.
[45] Kim, J.H., Lim, S., Park, K.S., et al. (2017) Total and Differential WBC Counts Are Related with Coronary Artery Atherosclerosis and In-crease the Risk for Cardiovascular Disease in Koreans. PLOS ONE, 12, e0180332. [Google Scholar] [CrossRef] [PubMed]

为你推荐